Assertio Holdings Inc. (NASDAQ: ASRT) announced a definitive agreement to be acquired by Garda Therapeutics for $18 per share in ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE